KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Inventory Average (2016 - 2025)

Historic Inventory Average for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to $347.4 million.

  • Emergent BioSolutions' Inventory Average rose 854.42% to $347.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $347.4 million, marking a year-over-year increase of 854.42%. This contributed to the annual value of $320.3 million for FY2024, which is 573.87% down from last year.
  • Latest data reveals that Emergent BioSolutions reported Inventory Average of $347.4 million as of Q3 2025, which was up 854.42% from $326.3 million recorded in Q2 2025.
  • Emergent BioSolutions' Inventory Average's 5-year high stood at $476.8 million during Q3 2022, with a 5-year trough of $312.8 million in Q1 2025.
  • Its 5-year average for Inventory Average is $362.2 million, with a median of $354.6 million in 2021.
  • Its Inventory Average has fluctuated over the past 5 years, first skyrocketed by 6372.08% in 2021, then tumbled by 2572.09% in 2023.
  • Over the past 5 years, Emergent BioSolutions' Inventory Average (Quarter) stood at $354.6 million in 2021, then increased by 23.95% to $439.4 million in 2022, then fell by 22.29% to $341.5 million in 2023, then fell by 7.12% to $317.2 million in 2024, then rose by 9.54% to $347.4 million in 2025.
  • Its Inventory Average was $347.4 million in Q3 2025, compared to $326.3 million in Q2 2025 and $312.8 million in Q1 2025.